In 2006, REPROCELL were one of the first companies to commercialize induced pluripotent stem cells (iPSCs). Today, we offer a complete portfolio of services for the reprogramming and differentiation of high quality iPSCs.
REPROCELL’s complete stem cell portfolio allows you to access:
Our expert scientists can design a bespoke project to compliment your unique research needs. With a dedicated study director to guide you through each experimental milestone, you can rest assured that REPROCELL will provide the cells you need – giving you more time to focus on research.
All REPROCELL projects are milestone based, meaning you are also guaranteed fair value and flexible customization of your chosen services (Figure 1).
|Figure 1: A typical stem cell project pipeline. Our scientists optimize reprogramming factors, culture conditions and protocol development according to your unique research requirements.|
At REPROCELL, each service contract is assigned a dedicated study director who is available for consultation throughout your entire project. Their role includes, but is not limited to:
At REPROCELL all projects are worth considering — no matter the size or complexity. And with service laboratories based in the USA, UK, India and Japan it is easier than ever to receive support from our teams. Armed with REPROCELL’s extensive experience in stem cell research, our scientists are dedicated to fulfilling your research needs.
|Figure 2: We have reprogramming technical experts and stem cell laboratories on three continents. (A.) Centre for Predictive Drug Discovery in REPROCELL Europe (Glasgow, Scotland) (B.) REPROCELL USA (Beltsville, MD) and (C.) REPROCELL HQ (Yokohama, Japan).|
Stem Cell Services
Zara Puckrin, BSc / 17 March 2021
Zara Puckrin, BSc / 9 March 2021
Katerina Boididou, MSc / 3 February 2021
22 March 2021
© 2021 REPROCELL Inc. All rights reserved.